PANATecs GmbH Appoints Rainer Baule, Chairman of the Board of Fresenius Kabi AG, to the Advisory Board

Tübingen, Germany, (PresseBox) - Prof. Peter Ruppersberg is leaving the Advisory Board of PANATecs GmbH on 27 April 2010 at his own wish. His successor is Rainer Baule, Member of the Board of Fresenius SE and Chairman of the Board of Fresenius Kabi AG.

Prof. Peter Ruppersberg has resigned his position as Member of the Advisory Board of the firm of PANATecs, as his business activities have shifted to Switzerland. He has been active in the Advisory Board of PANATecs GmbH since the founding and has made an essential contribution to the development of the company.

In the name of all partners, Dr. Benedikt Merz, Managing Director of PANATecs GmbH, thanked Prof. Peter Ruppersberg for his many years of trendsetting work in the Advisory Board, particularly when the company was starting and expanding.

Günter Steffen, Chairman of the Advisory Council of PANATecs GmbH, commented: "We are delighted that we have been able to persuade Mr. Rainer Baule to be Prof. Peter Ruppersberg's successor on the Advisory Board".

Rainer Baule has been a member of the Board of Fresenius SE since 1 June 1997. He has been Chairman of the Board of Fresenius Kabi AG since 7 May 2001. From 1996 to 1997, he was Chairman of the Board of Management of EG&G Berthold, Bad Wildbad. Since 1979, he has had various managerial positions in the Carl Zeiss Group in Oberkochen - both in Germany and in the USA. He was most recently company divisional director and member of Zeiss group management. His first position was as managing partner in Komeg-Kontroll-Technik GmbH, Riegelsberg. Rainer Baule studied industrial engineering at Darmstadt Technical University.*

Rainer Baule's work in the PANATecs GmbH Advisory Board will be in collaboration with the Chairman, Günter Steffen, ZFHN Zukunftsfonds Beteiligungs-Gmbh & Co. KG, and the Deputy Chairman, Prof. Gerhard Anton Müller MD, Faculty of Medicine, Göttingen University.


PANATecs GmbH is a young and innovative service provider for the pharmaceutical and biotechnology industries. PANATecs employs high technology based on mass spectrometry to characterize the drugs of the future, which are to be used for the treatment of diseases which are difficult to cure. PANATecs has set itself the objective of becoming the market leader in service provision in protein analysis and will continue to expand its international business during 2010.

PANATecs is a spinoff from Tübingen University and celebrated its fifth birthday in 2009. PANATecs' team of highly qualified scientists supports technological progress in the life sciences industry.

The company has been certified according to GMP Standards and ISO 9001.

Diese Pressemitteilungen könnten Sie auch interessieren

News abonnieren

Mit dem Aboservice der PresseBox, erhalten Sie tagesaktuell und zu einer gewünschten Zeit, relevante Presseinformationen aus Themengebieten, die für Sie interessant sind. Für die Zusendung der gewünschten Pressemeldungen, geben Sie bitte Ihre E-Mail-Adresse ein.

Es ist ein Fehler aufgetreten!

Vielen Dank! Sie erhalten in Kürze eine Bestätigungsemail.

Ich möchte die kostenlose Pressemail abonnieren und habe die Bedingungen hierzu gelesen und akzeptiert.